Lineagen Announces Launch of Proprietary Variant Index to Improve Interpretation of Genetic Basis for Childhood Developmental Delay

October 19, 2016

Lineagen, Inc. announced today the presentation at annual meeting of the American Society of Human Genetics (ASHG) and commercial launch of a Proprietary Variant Index
 

Read more

Lineagen Announces Identification of New Genetic Region Associated with Seizures in Wolf-Hirschhorn Syndrome

January 12, 2016

Lineagen, Inc. announced today the publication of a major study revealing a significant genetic contributor to epilepsy in Wolf Hirschhorn syndrome.

Read more

Lineagen Announces $19.8 Million Fundraising with Closing of $15.8 Million Series C Round

February 18, 2015

Funds to Support Continued Adoption of FirstStepDx PLUS and NextStepDx PLUS Tests for Pediatric Development Disorders

Read more

Lineagen Announces Identification of 39 Genetic Variants as Novel Risk Factors for Developing Autism Spectrum Disorder (ASD)

February 26, 2014

Unique research approach in ASD may lead to more powerful genetic diagnostic tests. Findings appear in the current issue of Molecular Autism.

Read more